Full Coverage
What to Know About Weight-Loss Drugs and Sleep Apnea
By Jessica Rendall
Top news
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and ...
Sleep apnea: Zepbound, Mounjaro improves symptoms in clinical trial
Lilly Pops After Weight-Loss Drug Succeeds In Sleep Apnea Study
By Allison Gatlin
UBS remains bullish on Inspire Medical after Lilly's OSA results - TipRanks.com
All coverage
Lilly obesity drug shows benefit in sleep disorder study, pointing to new use
By Jonathan D. Gardner
Pharmalittle: We're reading about Lilly's Zepbound for sleep apnea, the FDA budget, and more
By Ed Silverman
Eli Lilly's weight loss drug Zepbound could help treat sleep apnea — paving a way to Medicare coverage
By Bruce Gil
Weight-loss drug linked to sleep apnea reduction: Research
By Miranda Nazzaro
Tirzepatide Significantly Reduces OSA Symptoms in Phase 3 Trials, Lilly Looks Toward Mid-2024 Regulatory Submission
By Grace Halsey
Sleep Apnea: GLP-1 Drug Zepbound May Help Reduce Symptoms
By Shawn Radcliffe
Eli Lilly's weight loss drug Zepbound found to reduce sleep apnea, company says
By Berkeley Lovelace & Berkeley Lovelace Jr.
Lilly's Weight-Loss Drug Improved Sleep Apnea in Studies
By Madison Muller
Eli Lilly's Zepbound is promising treatment for sleep apnea
By Karen Weintraub & Eduardo Cuevas
This Semaglutide Maker Says Patients With Sleep Apnea on the Weight-Loss Drug Are Seeing Majorly Improved Sleep
By Alexandra Frost
Promise of Eli Lilly's weight-loss drug for sleep apnea adds reason to own
By Kevin Stankiewicz
